Juvederm Users Say AbbVie Hid Risks Of Filler
A putative class action filed in Illinois federal court claims AbbVie failed to adequately warn consumers that its Juvederm hyaluronic acid dermal fillers carry a significant risk of delayed-onset granulomas that...To view the full article, register now.
Already a subscriber? Click here to view full article